This false premise is not mine is not a basis for my doubts.
You are mixing things up. I do not use EPO studies in non-elites. I argue against those who attempt to use non-elite studies to show that EPO benefits elites similarly.
I use altitude studies on non-elites, not to argue benefits for elites, but to illustrate that we must consider all the factors, including non-doping factors, that can lead to higher blood values, and potentially improved performance.
If we witness significant improvements in performance, they can have legal causes.
This site was co-founded by someone who made significant gains in his 10K, after 5 years of competing at college, with Lydiard-like altitude training.
I don't make that presumption.
I prefer you to limit the discussion to blood doping, because lapsing into general vagaries as a response to my comments about blood doping creates confusion.
If you want to talk about all doping for distance events, we can have that discussion too.
We are in a thread about Russian doping.
By all accounts, no nation has doped more than Russia, and they have been at the forefront of doping since the Cold War.
Historical Russian performances match very well with my ideas about where all doping benefits endurance events.
The Russian men are notable for their absence in distance running, even if we just compare them to non-Africans.
I suspect their love for race-walking is partly driven by the knowledge of where doping works.
The Russian women have had some success in shorter distance events, events where the extra strength from male hormones may still contribute.
One Russian woman has had notable success in the marathon. Despite her extreme blood values, she was three minutes behind the world record. A deeper look at the best marathon performances shows that they are not as strong as Japan, a country not noted for doping.
I also note here that we are in a thread about a study of Russian women's performance, in a thread called "We Can Now Estimate the Effect of Blood Doping". This thread, and the study, presume the presence of only one doping factor, of blood-doping.
Will you acknowledge that this thread, and that study, are based on this false premise?
But this is the sandbox I'm being asked to argue in.
I'm not arguing that WADA needs to scientifically prove effect in elites in order to ban a substance or ban the athlete. That is a sandbox that no one is arguing in.
I'm not arguing to unban EPO or blood doping or to "apologize" for its use -- that is the red-herring.
And on the contrary, WADA takes that approach precisely because it cannot reliably estimate the effects of doping on performance.
The arbiters in doping cases do not decide on, and guilty verdicts do not depend on, whether specific performance benefits were realized. Dopers are convicted even when performances are slower, or there is no performance to judge (OOC).